Hansa Biopharma is an innovative and rapidly growing biopharmaceutical company that leverage its unique enzyme technology to develop innovative and potentially lifesaving and life altering immunomodulating therapies for rare autoimmune conditions, transplant rejection and cancer. 

Biotechnology

Hansa Biopharma

Søren Tulstrup

Gabriella Lindh von Koch

Gina Ewy

Emanuel Björne

Stephanie Kenney

Evan Ballantyne

Hitto Kaufmann

Suzanne Frank

Max Sakajja

Mark Wallace

Magnus Korsgren

Katja Gustafsson

Johan Oskarsson

Henk Doude van Troostwijk

Anne Säfström Lanner

The Scientific Research Team at Hansa Biopharma spearheads the development of groundbreaking immunomodulating therapies by conducting advanced biological research and clinical studies. This team, composed of experienced scientists and engineers, is responsible for exploring and validating new treatment pathways, optimizing bioanalysis methods, and overseeing critical projects to bring innovative solutions for rare autoimmune conditions, transplant rejection, and cancer from concept to clinical reality.

Scientific Research Team

Clinical Research Team

Business Development & Market Access

Scientific Research Team

About

Team members